Supplementation with a probiotic orally administered containing Bifidobacterium re-sensitized the tumors to anti-PD-L1 therapy in mice, by promoting DC maturation and an increase in anti-tumor CD8+ CTL activity33. The gene discussed is CD8A; the disease is neoplasm.